EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing

Stefania Byrou, Rutger W W Brouwer iD, Marios Tomazou iD, Stella Tamana iD, Petros Kountouris iD, Carsten W Lederer iD, Miranda Petrou, Zeliha Ozgur, Xander den Dekker iD, Zakia Azmani, Soteroula Christou, Christiana Makariou und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Stefania Byrou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus. Hauptthemen laut MEDLINE: beta-Thalassemia, High-Throughput Nucleotide Sequencing, Cell-Free Nucleic Acids, Paternal Inheritance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Research and Innovation Foundation, Excellence Hubs Program of The Research and Innovation Foundation (RIF), “Restart 2016–2020”, The Cyprus Institute of Neurology & Genetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-invasive prenatal testing (NIPT) has been widely adopted for the screening of chromosomal abnormalities; however, its adoption for monogenic disorders, such as β-thalassaemia, has proven challenging. Haemoglobinopathies are the most common monogenic disorders globally, with β-thalassaemia being particularly prevalent in Cyprus. This study introduces a non-invasive prenatal haplotyping (NIPH) assay for β-thalassaemia, utilizing cell-free DNA (cfDNA) from maternal plasma. The assay determines paternal inheritance by analyzing highly heterozygous single-nucleotide variants (SNVs) in the β-globin gene cluster. To identify highly heterozygous SNVs in the population, 96 randomly selected samples were processed using Illumina DNA-prep NGS chemistry. A custom, high-density NGS genotyping panel, named HAPLONID, was designed with 169 SNVs, including 15 common pathogenic ones. The AmpliSeq for Illumina assay was then applied to cfDNA to evaluate the panel’s efficiency in performing NIPT for β-thalassaemia. Analysis revealed 219 highly polymorphic SNVs, and the sequencing of 17 families confirmed successful paternal allele determination. The NIPH assay demonstrated 100% success in diagnostic interpretation. This study achieved the advancement of an integrated NGS-NIPT assay for β-thalassaemia, bringing it one step closer to being a diagnostic assay and thereby enabling a reduction in the number of risky invasive prenatal sampling procedures in Cyprus and elsewhere.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaHigh-Throughput Nucleotide SequencingCell-Free Nucleic AcidsPaternal InheritancePrenatal DiagnosisNoninvasive Prenatal TestingHumansFemalePregnancyMalePolymorphism, Single Nucleotidebeta-GlobinsAdultHaplotypesFetus

Stichwörter der Autor:innen

cell-free DNA (cfDNA)haplotype analysismonogenic disordersnon-invasive prenatal testing (NIPT)β-thalassaemia

Substanzen

Cell-Free Nucleic Acidsbeta-Globins

Autor:innen und Institutionen

  • Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
  • Department of Cell Biology, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
  • Center for Biomics, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
  • Nicosia Thalassaemia Clinic, Archbishop Makarios III Hospital, Nicosia 2371, Cyprus.
  • Thalassaemia Screening Laboratory, Thalassaemia Center, Archbishop Makarios III Hospital, Nicosia 2371, Cyprus.

ORCID-Profile: Rutger W W Brouwer, Marios Tomazou, Stella Tamana, Petros Kountouris, Carsten W Lederer, Xander den Dekker, Marina Kleanthous, Wilfred F J van IJcken, Thessalia Papasavva

Förderung

  • The Research and Innovation Foundation
  • Excellence Hubs Program of The Research and Innovation Foundation (RIF), “Restart 2016–2020”
  • The Cyprus Institute of Neurology & Genetics

Zitieren

APA

Byrou, S., Brouwer, R. W. W., Tomazou, M., Tamana, S., Kountouris, P., Lederer, C. W., Petrou, M., Ozgur, Z., den Dekker, X., Azmani, Z., Christou, S., Makariou, C., Kleanthous, M., IJcken, W. F. J. V., & Papasavva, T. (2025). Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020570

Vancouver

Byrou S, Brouwer RWW, Tomazou M, Tamana S, Kountouris P, Lederer CW, et al. Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020570

BibTeX
@article{Byrou2025,
  author = {Byrou, Stefania and Brouwer, Rutger W W and Tomazou, Marios and Tamana, Stella and Kountouris, Petros and Lederer, Carsten W and Petrou, Miranda and Ozgur, Zeliha and den Dekker, Xander and Azmani, Zakia and Christou, Soteroula and Makariou, Christiana and Kleanthous, Marina and IJcken, Wilfred F J van and Papasavva, Thessalia},
  title = {Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020570}
}
Kostenlos starten →